MENU
+Compare
BGLAF
Stock ticker: OTC
AS OF
Nov 20 closing price
Price
$10.24
Change
-$0.18 (-1.73%)
Capitalization
1.07B

BGLAF Biogaia AB Forecast, Technical & Fundamental Analysis

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products... Show more

BGLAF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BGLAF with price predictions
Nov 28, 2025

Momentum Indicator for BGLAF turns negative, indicating new downward trend

BGLAF saw its Momentum Indicator move below the 0 level on November 20, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator turned negative. In of the 6 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.026) is normal, around the industry mean (17.312). P/E Ratio (30.972) is within average values for comparable stocks, (72.847). BGLAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). Dividend Yield (0.020) settles around the average of (0.030) among similar stocks. P/S Ratio (6.684) is also within normal values, averaging (55.504).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BGLAF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGLAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
BGLAF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbroplan 3A
Phone
+46 855529300
Employees
164
Web
https://www.biogaia.se
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMHX42.85N/A
N/A
MFS Emerging Markets Equity R4
PGIAX40.21N/A
N/A
Putnam Focused Equity A
OALGX24.31N/A
N/A
Optimum Large Cap Growth A
EIISX17.29N/A
N/A
Parametric International Equity I
ACWZX20.13N/A
N/A
AMG GW&K Small/Mid Cap Growth Z

BGLAF and Stocks

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-1.55%
CTTH - BGLAF
28%
Poorly correlated
N/A
SHPH - BGLAF
8%
Poorly correlated
-5.99%
SDZXF - BGLAF
5%
Poorly correlated
N/A
TSNDF - BGLAF
3%
Poorly correlated
N/A
More

Groups containing BGLAF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
Pharmaceuticals
category (377 stocks)
11%
Poorly correlated
+0.67%
Pharmaceuticals: Generic
category (213 stocks)
2%
Poorly correlated
+0.76%